A detailed history of Neuberger Berman Group LLC transactions in Haleon PLC stock. As of the latest transaction made, Neuberger Berman Group LLC holds 976,666 shares of HLN stock, worth $9.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
976,666
Previous 1,013,012 3.59%
Holding current value
$9.17 Million
Previous $8.37 Million 23.5%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.32 - $10.7 $302,398 - $388,902
-36,346 Reduced 3.59%
976,666 $10.3 Million
Q2 2024

Nov 14, 2024

BUY
$8.01 - $8.64 $274,022 - $295,574
34,210 Added 3.5%
1,013,012 $8.37 Million
Q2 2024

Aug 13, 2024

BUY
$8.01 - $8.64 $274,022 - $295,574
34,210 Added 3.5%
1,013,012 $8.37 Million
Q1 2024

Nov 14, 2024

BUY
$8.02 - $8.67 $5.18 Million - $5.6 Million
646,340 Added 194.41%
978,802 $8.31 Million
Q1 2024

May 13, 2024

BUY
$8.02 - $8.67 $7.85 Million - $8.49 Million
978,802 New
978,802 $8.31 Million
Q4 2023

Nov 14, 2024

SELL
$7.78 - $8.62 $5.29 Million - $5.87 Million
-680,550 Reduced 67.18%
332,462 $2.74 Million
Q4 2023

Feb 09, 2024

SELL
$7.78 - $8.62 $291,026 - $322,448
-37,407 Reduced 10.11%
332,462 $2.74 Million
Q3 2023

Nov 14, 2023

BUY
$7.85 - $8.94 $975,174 - $1.11 Million
124,226 Added 50.57%
369,869 $3.08 Million
Q2 2023

Aug 11, 2023

BUY
$8.04 - $9.0 $1.27 Million - $1.42 Million
158,180 Added 180.85%
245,643 $2.06 Million
Q1 2023

May 12, 2023

SELL
$7.57 - $8.37 $18,940 - $20,941
-2,502 Reduced 2.78%
87,463 $711,000
Q4 2022

Feb 13, 2023

SELL
$5.96 - $8.06 $32,499 - $43,951
-5,453 Reduced 5.71%
89,965 $719,000
Q3 2022

Nov 15, 2022

BUY
$5.63 - $7.5 $537,203 - $715,635
95,418 New
95,418 $581,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.